A
Ataraxis AI
Biotech & Life Sciences · New York City, United States · Founded 2023
AI-driven diagnostic tests enhancing precision medicine with rapid, personalized cancer prognostics MoreLess
Ataraxis AI is a precision medicine company focused on revolutionizing cancer diagnostics through advanced AI technology. With a recent emergence from stealth mode and backed by $4 million in seed funding, Ataraxis AI has introduced its first product, Ataraxis Breast, an AI-native prognostic test for breast cancer. This test is designed to significantly improve the prediction of patient outcomes, allowing for more precise and personalized treatment plans. Operating in the healthcare sector, particularly in oncology, Ataraxis AI serves physicians and healthcare providers by offering rapid diagnostic results within one business day. The company's business model revolves around providing these AI-powered diagnostic tests, which are accessible through a physician portal or delivered directly to clinicians. By leveraging AI, Ataraxis AI aims to set a new standard in molecular diagnostics, traditionally the benchmark for personalized treatment selection. Keywords: AI, precision medicine, cancer diagnostics, breast cancer, prognostic test, oncology, personalized treatment, healthcare, molecular diagnostics, rapid results.
Company overview
Ataraxis AI company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2023
- Headquarters
- New York City, United States
- Employees
- 43
- Open positions
- 17
- Dealroom signal
- 89.0
Valuation & funding
Ataraxis AI funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Aug 2026 | $20M | $82M | Bertelsmann · Obvious Ventures · Founders Fund · Giant Ventures | ↗ |
| SERIES A✓Equity / VC | Jan 2025 | $20M | $82M | Founders Fund · Floating Point · Thiel Bio · Giant Ventures | ↗ |
| SEED✓Equity / VC | Oct 2024 | $4M | $16M | Obvious Ventures · Giant Ventures | ↗ |
| SPINOUT✓Other financing | Jan 2023 | $0 | — | New York University | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 48 |
| 2025 | 1 |
| 2024 | 1 |
Growth signals
Ataraxis AI website traffic
Latest recorded traffic for Ataraxis AI is 4.8K monthly website visits, down 12.7% over the last three months. Ataraxis AI's team grew 4200% over the past year.
Hiring
Open positions at Ataraxis AI
Current openings linked to this company in Dealroom.
Comparisons
Ataraxis AI compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Ataraxis AI's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Ataraxis AI has talent and traffic
team presence
In the news
Latest news about Ataraxis AI
Recent press, funding announcements, and product moves mentioning Ataraxis AI — open to read from the original sources.
Market sentiment
What the market is saying about Ataraxis AI
An AI-synthesized read of the highest-engagement posts about Ataraxis AI on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ataraxis AI’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.